# OnCo record cobas-ezh2-mutation-test (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cobas-ezh2-mutation-test/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "cobas-ezh2-mutation-test" ;
  schema:name "cobas EZH2 Mutation Test"@en ;
  schema:description "The Roche test that found an EZH2 mutation in follicular lymphoma to select tazemetostat. Tazemetostat has since been withdrawn, and the FDA records the test's own approval as withdrawn on 6 July 2026."@en ;
  schema:url <https://onco.cc/drugs/cobas-ezh2-mutation-test/> ;
  schema:dateModified "2026-11-19"^^xsd:date ;
  schema:citation <https://api.fda.gov/device/pma.json?search=pma_number:P200014+AND+supplement_number:%22%22>, <https://open.fda.gov/fields/devicepma.yaml>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P200014>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-fda-authorized-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "withdrawn" ;
  onco:tag "test" ;
  onco:modality "Real-time allele-specific PCR companion diagnostic test (EZH2 mutations, follicular lymphoma tissue)" ;
  schema:alternateName "cobas EZH2 Mutation Test" ;
  onco:approval "US 2020: Companion diagnostic for tazemetostat in EZH2-mutant follicular lymphoma" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/ezh2/> ;
  onco:drugs <https://onco.cc/drugs/tazemetostat/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> ;
  onco:terms <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/companion-diagnostic-term/> .
